Business
ProQR Announces Virtual Presentations at Scientific Conferences
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 24, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives
About this update from Proqr Therapeutics N.v.
[{"type":"text","content":"LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 24, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced virtual presentations at the Ophthalmology Futures Retina Forum, European Society of Retina Specialists (Euretina) congress and the Annual Meeting of the American Academy of Optometry (AAOpt).\n ProQR’s presentation at Ophthalmology Futures Retina Forum Presentation title: Advancements in Inherited Retinal Diseases Management Presenter: Aniz Girach, MD, Chief Medical Officer of ProQR Date: September 30, 2020 ProQR’s presentations at Euretina Presentation title: Phase 1b/2 trial results of intravitreal sepofarsen RNA therapy in Leber congenital amaurosis 10 (LCA10) Presenter: Stephen R. Russell, MD, principal investigator of the ProQR Phase 1/2 clinical trial of sepofarsen Professor and Director of Vitreoretinal Diseases and Surgery Service, Department of Ophthalmology and Visual Sciences, University of Iowa Date: The poster presentation will be available on the Euretina Virtual Congress portal starting October 2, 2020. Presentation title: RNA antisense oligonucleotide sepofarsen in Leber Congenital Amaurosis type 10 (LCA10): disease severity and patient response based on genotype Presenter: Bart P. Leroy, MD, PhD, principal investigator of the ProQR Phase 1/2 clinical trial of sepofarsen and Chairman and Head of the Department of Ophthalmology at the Center for Medical Genetics at the Ghent University Date: The poster presentation will be available on the Euretina Virtual Congress portal starting October 2, 2020. ProQR’s presentation at AAOpt Presentation title: Survey of Early Genetic Diagnosis of Inherited Retinal Diseases (IRDs) and Patient Referrals: The important role of Optometrists in the early management of blinding genetic diseases Presenter: Ramiro S. Maldonado, MD, Assistant Professor of Ophthalmology at Shriners UK Advances Eye Care at the University of Kentucky Date: The poster presentation will be available on the AAOpt Virtual Platform starting October 7, 2020. A live questions and answers session will be held on Friday October 9, 2020, 7:30-9:30 PM EDT. About Sepofarsen Sepofarsen (QR-110) is being evaluated in the pivotal Phase 2/3 Illuminate trial and is a firs...